The value of days alive and out of hospital 30 days after surgery as an outcome measure in a major cardiac surgical center in Australia

IF 1.9
JTCVS open Pub Date : 2026-02-01 Epub Date: 2025-12-11 DOI:10.1016/j.xjon.2025.101556
Rona P. Steel BMedSci, CCP (Aust) , Jeremy D. Field BSc(Hons), FANZCA , Jan M. Dieleman PhD, FANZCA
{"title":"The value of days alive and out of hospital 30 days after surgery as an outcome measure in a major cardiac surgical center in Australia","authors":"Rona P. Steel BMedSci, CCP (Aust) ,&nbsp;Jeremy D. Field BSc(Hons), FANZCA ,&nbsp;Jan M. Dieleman PhD, FANZCA","doi":"10.1016/j.xjon.2025.101556","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Postoperative days alive and out of hospital within 30 days (DAH-30) is a validated, patient-centered metric reflecting the quality of care and recovery after surgery. This study aimed to evaluate the feasibility of DAH-30 data collection in an Australian cardiac surgical center and investigate its association with established cardiac risk factors and postoperative complications.</div></div><div><h3>Methods</h3><div>This retrospective cohort study used prospectively collected registry data from patients aged ≥18 years undergoing open-heart surgery. DAH-30 was calculated as the total number of days alive and out of hospital within the first 30 postoperative days, incorporating manually collected data on secondary facility discharge and readmission. Univariable associations were assessed using the Kruskal-Wallis rank sum test. Multivariable analysis used a backward stepwise selection procedure on the parameters of a beta-inflated regression model. Estimated coefficients, 95% confidence intervals, and <em>P</em> values were reported.</div></div><div><h3>Results</h3><div>DAH-30 data collection was efficiently integrated into routine clinical workflow. The median DAH-30 for the cohort was 21 days (interquartile range, 14-23), with 10.6% of patients spending no time at home within 30 days. Univariable analysis revealed significant associations between several preoperative risk factors and postoperative complications with DAH-30. Multivariable analysis identified age, postoperative arrhythmias, and preoperative infective endocarditis as independent predictors of reduced DAH-30.</div></div><div><h3>Conclusions</h3><div>DAH-30 is a feasible, meaningful patient-centered outcome metric that can be efficiently collected using routine clinical data in an Australian cardiac surgical center. It provides valuable insights into patient recovery by integrating the impact of preoperative risk, postoperative complications, and hospital use. DAH-30 holds potential as an important outcome measure in cardiac surgery for guiding clinical practice, informing quality improvement, and monitoring intervention effectiveness.</div></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"29 ","pages":"Article 101556"},"PeriodicalIF":1.9000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTCVS open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666273625004875","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/11 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Postoperative days alive and out of hospital within 30 days (DAH-30) is a validated, patient-centered metric reflecting the quality of care and recovery after surgery. This study aimed to evaluate the feasibility of DAH-30 data collection in an Australian cardiac surgical center and investigate its association with established cardiac risk factors and postoperative complications.

Methods

This retrospective cohort study used prospectively collected registry data from patients aged ≥18 years undergoing open-heart surgery. DAH-30 was calculated as the total number of days alive and out of hospital within the first 30 postoperative days, incorporating manually collected data on secondary facility discharge and readmission. Univariable associations were assessed using the Kruskal-Wallis rank sum test. Multivariable analysis used a backward stepwise selection procedure on the parameters of a beta-inflated regression model. Estimated coefficients, 95% confidence intervals, and P values were reported.

Results

DAH-30 data collection was efficiently integrated into routine clinical workflow. The median DAH-30 for the cohort was 21 days (interquartile range, 14-23), with 10.6% of patients spending no time at home within 30 days. Univariable analysis revealed significant associations between several preoperative risk factors and postoperative complications with DAH-30. Multivariable analysis identified age, postoperative arrhythmias, and preoperative infective endocarditis as independent predictors of reduced DAH-30.

Conclusions

DAH-30 is a feasible, meaningful patient-centered outcome metric that can be efficiently collected using routine clinical data in an Australian cardiac surgical center. It provides valuable insights into patient recovery by integrating the impact of preoperative risk, postoperative complications, and hospital use. DAH-30 holds potential as an important outcome measure in cardiac surgery for guiding clinical practice, informing quality improvement, and monitoring intervention effectiveness.
澳大利亚一家大型心脏外科中心手术后30天存活和出院天数的价值
目的:术后30天内存活天数和出院天数(ah -30)是一个有效的、以患者为中心的指标,反映了手术后护理质量和恢复情况。本研究旨在评估在澳大利亚心脏外科中心收集DAH-30数据的可行性,并探讨其与既定心脏危险因素和术后并发症的关系。方法回顾性队列研究前瞻性收集年龄≥18岁接受心脏直视手术患者的登记资料。DAH-30计算为术后前30天内存活和出院的总天数,结合人工收集的二级医院出院和再入院数据。采用Kruskal-Wallis秩和检验评估单变量关联。多变量分析使用了对β膨胀回归模型参数的反向逐步选择程序。报告了估计系数、95%置信区间和P值。结果dah -30数据采集能有效地融入临床常规工作流程。该队列的中位DAH-30为21天(四分位数范围为14-23),10.6%的患者在30天内没有呆在家里。单变量分析显示,一些术前危险因素与DAH-30术后并发症之间存在显著关联。多变量分析发现,年龄、术后心律失常和术前感染性心内膜炎是降低DAH-30的独立预测因素。结论dah -30是一种可行的、有意义的以患者为中心的预后指标,可以通过澳大利亚心脏外科中心的常规临床数据有效收集。它通过整合术前风险、术后并发症和医院使用的影响,为患者康复提供了有价值的见解。DAH-30在指导临床实践、提高质量和监测干预效果方面具有重要的预后指标潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书